| Dr Kevin Kuen-dar Ho, MD | |
|
7835 Boulevard 26, North Richland Hills, TX 76180-7105 | |
| (817) 589-1822 | |
| (817) 595-4597 |
| Full Name | Dr Kevin Kuen-dar Ho |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 23 Years |
| Location | 7835 Boulevard 26, North Richland Hills, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396842936 | NPI | - | NPPES |
| 200862800 | Medicaid | IN | |
| 215262101 | Medicaid | TX | |
| P00928215 | Other | TX | RRMC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01063410 (Indiana) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | N5107 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hospital Alliance | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 2 days ago
| Entity Name | The Austin Diagnostic Clinic, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003259763 PECOS PAC ID: 1254244551 Enrollment ID: O20031112000236 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 2 days ago
| Entity Name | Digestive Health Associates Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831158310 PECOS PAC ID: 2769372150 Enrollment ID: O20040318001014 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 2 days ago
| Entity Name | Texas Digestive Disease Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053397331 PECOS PAC ID: 3375531379 Enrollment ID: O20040505001844 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Kuen-dar Ho, MD 7610 N Stemmons Fwy Ste 600, Dallas, TX 75247-4228 Ph: (214) 689-5960 | Dr Kevin Kuen-dar Ho, MD 7835 Boulevard 26, North Richland Hills, TX 76180-7105 Ph: (817) 589-1822 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
Oncolytics Biotech Inc. has reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo.
› Verified 2 days ago
Dr. Bryan Allan Ong, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 7620 Ne Loop 820, North Richland Hills, TX 76180 Phone: 817-284-2693 Fax: 817-284-1819 | |
Dr. David Raj Bass, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4375 Booth Calloway Rd, #307, North Richland Hills, TX 76180 Phone: 682-463-0400 Fax: 682-463-0405 | |
Prasad Venkata Kannaeganti, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6331 Boulevard 26, Suite 220, North Richland Hills, TX 76180 Phone: 817-628-0284 Fax: 817-628-0288 | |
Dr. Cherian Abraham, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7835 Boulevard 26, North Richland Hills, TX 76180 Phone: 817-589-1822 Fax: 817-595-4597 | |
Ira M Epstein, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6331 Boulevard 26, Ste 220, North Richland Hills, TX 76180 Phone: 817-628-0284 Fax: 817-628-0288 | |
Dr. Mark D Murray, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7620 Ne Loop 820, North Richland Hills, TX 76180 Phone: 817-284-2693 Fax: 817-284-1819 | |
John M Sturgeon Iii, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4300 City Point Dr Ste 200, North Richland Hills, TX 76180 Phone: 817-255-1940 |